| Authors: |
Vo JB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. Electronic address: jacqueline.vo@nih.gov., Brandt C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Taparra K; Department of Health Policy and Management, Fielding School of Public Health, Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Ramin C; Cancer Research Center for Health Equity, Division of Population Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA., Berrington de González A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom., Gierach GL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Lawrence WR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Rhee J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Shiels MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Veiga LHS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Mitra PR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Shing JZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Yi SS; Department of Population Health, NYU Langone Health, New York, New York, USA. |
